Sponsored by Oregon Business

Druker honored as first citizen

| Print |  Email
High Five
Thursday, April 22, 2010

Cancer researcher Brian Druker is Portland's new "first citizen," the latest of many awards for the head of OHSU's Knight Cancer Institute.

Druker was the lead researcher in developing the drug Gleevec, which has saved countless lives over the past decade.

Before Gleevec was approved for sale in 2001, close to a third of CML patients died within five years of diagnosis. Now, that death rate is closer to one in 10, and many die from causes unrelated to cancer. Gleevec is also being used against several other cancers.

Read more at Oregon Live.

Oregon Business magazinetitle-sponsored-links-02